0

IN THIS ISSUE

Archives of Neurology

December 2009, Vol 66, No. 12
Basic View  |  Expanded View
About This Journal FREE
Topics:
Arch Neurol. 2009;66(12):1440-1440.  doi: 10.1001/archneur.66.12.1440
This Month in Archives of Neurology FREE
Topics:
Arch Neurol. 2009;66(12):1442-1444.  doi: 10.1001/archneurol.2009.274
Natural Oxidant Balance in Parkinson Disease
George Perry, PhD; Paula I. Moreira, PhD; Sandra L. Siedlak, BA; Akihiko Nunomura, MD; Xiongwei Zhu, PhD; Mark A. Smith, PhD
Topics: parkinson disease, oxidants
Arch Neurol. 2009;66(12):1445-1445.  doi: 10.1001/archneurol.2009.261
Mild Cognitive Impairment: Title and subTitle BreakTen Years LaterMild Cognitive Impairment FREE
Ronald C. Petersen, PhD, MD; Rosebud O. Roberts, MB, ChB; David S. Knopman, MD; Bradley F. Boeve, MD; Yonas E. Geda, MD; Robert J. Ivnik, PhD; Glenn E. Smith, PhD; Clifford R. Jack, MD
Topics: minimal cognitive impairment
Arch Neurol. 2009;66(12):1447-1455.  doi: 10.1001/archneurol.2009.266
Cellular Mechanisms of Central Nervous System Repair by Natural Autoreactive Monoclonal AntibodiesNatural Autoreactive Monoclonal IgM in CNS Repair FREE
Brent R. Wright, PhD; Arthur E. Warrington, PhD; Dale E. Edberg, PhD; Moses Rodriguez, MD
Topics: central nervous system, monoclonal antibodies, tissue membrane, oligodendroglia, immunoglobulin m, antibodies, igm antibody, binding, myelin, binding (molecular function)
Arch Neurol. 2009;66(12):1456-1459.  doi: 10.1001/archneurol.2009.262
Urate as a Predictor of the Rate of Clinical Decline in Parkinson DiseaseUrate Level and Clinical Decline Rate in PD FREE
Alberto Ascherio, MD, DrPH; Peter A. LeWitt, MD; Kui Xu, MD, PhD; Shirley Eberly, MS; Arthur Watts, BS; Wayne R. Matson, PhD; Connie Marras, MD; Karl Kieburtz, MD; Alice Rudolph, PhD; Mikhail B. Bogdanov, PhD; Steven R. Schwid, MD; Marsha Tennis, RN; Caroline M. Tanner, MD, PhD; M. Flint Beal, MD; Anthony E. Lang, MD; David Oakes, PhD; Stanley Fahn, MD; Ira Shoulson, MD; Michael A. Schwarzschild, MD, PhD;
Includes: Supplemental Content
Topics: parkinson disease, recombinant colony-stimulating factors, urate level
Arch Neurol. 2009;66(12):1460-1468.  doi: 10.1001/archneurol.2009.247
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer DiseasePiB and Progression From Cognitive Normality to AD FREE
John C. Morris, MD; Catherine M. Roe, PhD; Elizabeth A. Grant, PhD; Denise Head, PhD; Martha Storandt, PhD; Alison M. Goate, DPhil; Anne M. Fagan, PhD; David M. Holtzman, MD; Mark A. Mintun, MD
Includes: CME
Topics: positron-emission tomography, alzheimer's disease, dementia, diagnostic imaging, pittsburgh compound b, normality
Arch Neurol. 2009;66(12):1469-1475.  doi: 10.1001/archneurol.2009.269
Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B: Title and subTitle BreakCognitive Decline Associated With Aβ Deposition FREE
Martha Storandt, PhD; Mark A. Mintun, MD; Denise Head, PhD; John C. Morris, MD
Topics: amyloid, peptides, brain, diagnostic imaging, cognitive impairment, pittsburgh compound b, brain volume
Arch Neurol. 2009;66(12):1476-1481.  doi: 10.1001/archneurol.2009.272
Transactive Response DNA-Binding Protein 43 Burden in Familial Alzheimer Disease and Down SyndromeTDP-43 in Familial Alzheimer Disease and Down Syndrome FREE
Carol F. Lippa, MD; Andrea L. Rosso, MPH; Lauren D. Stutzbach, BA; Manuela Neumann, MD; Virginia M.-Y. Lee, PhD; John Q. Trojanowski, MD, PhD
Topics: down syndrome, alzheimer's disease, dna, protein tdp-43
Arch Neurol. 2009;66(12):1483-1488.  doi: 10.1001/archneurol.2009.277
Characteristics and Surgical Outcomes of Patients With Refractory Magnetic Resonance Imaging–Negative EpilepsiesSurgical Outcomes of MRI-Negative Epilepsies FREE
Christian G. Bien, MD; Miriam Szinay, MD; Jan Wagner, MD; Hans Clusmann, MD; Albert J. Becker, MD; Horst Urbach, MD
Topics: magnetic resonance imaging, epilepsy
Arch Neurol. 2009;66(12):1491-1499.  doi: 10.1001/archneurol.2009.283
Status Epilepticus Associated With Subtentorial Posterior Fossa LesionsSE and Subtentorial Posterior Fossa Lesions FREE
Marie F. Grill, MD; David M. Treiman, MD; Rama K. Maganti, MD
Topics: posterior fossa of cranial cavity, electroencephalography, status epilepticus
Arch Neurol. 2009;66(12):1500-1504.  doi: 10.1001/archneurol.2009.275
Functional and Cognitive Outcome in Prolonged Refractory Status EpilepticusOutcomes in Prolonged Refractory Status Epilepticus FREE
Alex D. Cooper, MD; Jeffrey W. Britton, MD; Alejandro A. Rabinstein, MD
Topics: status epilepticus
Arch Neurol. 2009;66(12):1505-1509.  doi: 10.1001/archneurol.2009.273
Genotype-Phenotype Correlations in Charcot-Marie-Tooth Disease Type 2 Caused by Mitofusin 2 MutationsGenotype-Phenotype Correlations in CMT2 FREE
Judith Calvo, MD; Benoît Funalot, MD, PhD; Robert A. Ouvrier, MD; Leila Lazaro, MD; Annick Toutain, MD, PhD; Philippe De Mas, MD; Pierre Bouche, MD; Brigitte Gilbert-Dussardier, MD; Marie-Christine Arne-Bes, MD; Jean-Pierre Carrière, MD; Hubert Journel, MD; Marie-Christine Minot-Myhie, MD; Claire Guillou, MD; Karima Ghorab, MD; Laurent Magy, MD, PhD; Franck Sturtz, MD, PhD; Jean-Michel Vallat, MD; Corinne Magdelaine, PhD
Topics: phenotype, charcot-marie-tooth disease, mutation, genotype, mfn2 gene
Arch Neurol. 2009;66(12):1511-1516.  doi: 10.1001/archneurol.2009.284
Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson DiseaseMotor Phenotype of LRRK2 G2019S Carriers FREE
Roy N. Alcalay, MD; Helen Mejia-Santana, MSc; Ming Xin Tang, PhD; Llency Rosado, MD; Miguel Verbitsky, PhD; Sergey Kisselev, MS; Barbara M. Ross, BSc; Elan D. Louis, MD, MSc; Cynthia L. Comella, MD; Amy Colcher, MD; Danna Jennings, MD; Martha A. Nance, MD; Susan Bressman, MD; William K. Scott, PhD; Caroline Tanner, MD, PhD; Susan F. Mickel, MD; Howard F. Andrews, PhD; Cheryl H. Waters, MD; Stanley Fahn, MD; Lucien J. Cote, MD; Steven J. Frucht, MD; Blair Ford, MD; Michael Rezak, MD, PhD; Kevin Novak, PhD; Joseph H. Friedman, MD; Ronald Pfeiffer, MD; Laura Marsh, MD; Bradley Hiner, MD; Andrew Siderowf, MD, MSCE; Elise Caccappolo, PhD; Ruth Ottman, PhD; Lorraine N. Clark, PhD; Karen S. Marder, MD, MPH
Topics: phenotype, parkinson disease, mutation, levodopa, proband, unified parkinson's disease rating scale, lrrk2 gene, illness length
Arch Neurol. 2009;66(12):1517-1522.  doi: 10.1001/archneurol.2009.267
Heterogeneity in Infarct Patterns and Clinical Outcomes Following Internal Carotid Artery OcclusionOutcomes After Internal Carotid Artery Occlusion FREE
Thanh G. Phan, FRACP, PhD; Geoffrey A. Donnan, FRACP, MD; Velandai Srikanth, FRACP, PhD; Jian Chen, ME; David C. Reutens, FRACP, MD
Topics: carotid artery, internal, occlusion, heterogeneity, infarction, treatment outcome
Arch Neurol. 2009;66(12):1523-1528.  doi: 10.1001/archneurol.2009.259
HLA-DRB1*1501 and Spinal Cord Magnetic Resonance Imaging Lesions in Multiple SclerosisHLA-DRB1*1501 and Spinal Cord MR Lesions in MS FREE
Madeleine H. Sombekke, MD; Carsten Lukas, MD; J. Bart A. Crusius, PhD; Diego Tejedor, PhD; Joep Killestein, MD, PhD; David Arteta, PhD; Antonio Martínez, PhD; Bernard M. J. Uitdehaag, MD, PhD; Dirk L. Knol, PhD; A. Salvador Peña, MD, PhD; Jeroen J. G. Geurts, PhD; Philip L. De Jager, MD, PhD; Frederik Barkhof, MD, PhD; Hugo Vrenken, PhD; Chris H. Polman, MD, PhD
Includes: Supplemental Content
Topics: magnetic resonance imaging, multiple sclerosis, single nucleotide polymorphism, brain, spinal cord, hla-drb1 gene
Arch Neurol. 2009;66(12):1531-1536.  doi: 10.1001/archneurol.2009.278
High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation TypesHigh Striatal Aβ Deposition and AD FREE
Victor L. Villemagne, MD; Suzuka Ataka, MD, PhD; Toshiki Mizuno, MD, PhD; William S. Brooks, MD; Yasuhiro Wada, PhD; Masaki Kondo, MD, PhD; Gareth Jones, BSc(Hon); Yasuyoshi Watanabe, MD, PhD; Rachel Mulligan, PhD; Masanori Nakagawa, MD, PhD; Takami Miki, MD; Hiroyuki Shimada, MD, PhD; Graeme J. O’Keefe, PhD; Colin L. Masters, MD; Hiroshi Mori, PhD; Christopher C. Rowe, MD
Topics: amyloid, alzheimer's disease, mutation, peptides, human placental lactogen, diagnostic imaging, psen1 gene
Arch Neurol. 2009;66(12):1537-1544.  doi: 10.1001/archneurol.2009.285
Quantitative Template for Subtyping Primary Progressive AphasiaSubtyping Primary Progressive Aphasia FREE
Marsel Mesulam, MD; Christina Wieneke, BA; Emily Rogalski, PhD; Derin Cobia, PhD; Cynthia Thompson, PhD; Sandra Weintraub, PhD
Topics: aphasia, primary progressive, languages, semantics, naming function
Arch Neurol. 2009;66(12):1545-1551.  doi: 10.1001/archneurol.2009.288
Cerebrospinal Fluid β-Amyloid 42, Tau, and P-tau: Title and subTitle BreakConfirmation Now RealizationCerebrospinal Fluid β-Amyloid 42, Tau, and P-tau
David M. Holtzman, MD
Topics:
Arch Neurol. 2009;66(12):1552-1553.  doi: 10.1001/archneurol.2009.270
Surgery Is the Best Option for Intractable Unilateral Mesial Temporal EpilepsySurgery for Unilateral Mesial Temporal Epilepsy
Paul C. Van Ness, MD
Topics:
Arch Neurol. 2009;66(12):1554-1556.  doi: 10.1001/archneurol.2009.276
Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease: Title and subTitle BreakA Case ReportPiB PET Detection of Cerebral Aβ vs Preexisting AD Markers FREE
Nigel J. Cairns, PhD; Milos D. Ikonomovic, MD; Tammie Benzinger, MD; Martha Storandt, PhD; Anne M. Fagan, PhD; Aarti R. Shah, MS; Lisa Taylor Reinwald, BA; Deborah Carter; Angela Felton, BS; David M. Holtzman, MD; Mark A. Mintun, MD; William E. Klunk, MD; John C. Morris, MD
Topics: amyloid, positron-emission tomography, alzheimer's disease, brain, cerebrospinal fluid, pittsburgh compound b, pet animal
Arch Neurol. 2009;66(12):1557-1562.  doi: 10.1001/archneurol.2009.279
Symptomatic Narcolepsy in Patients With Neuromyelitis Optica and Multiple Sclerosis: Title and subTitle BreakNew Neurochemical and Immunological ImplicationsSymptomatic Narcolepsy in NMO and MS FREE
Takashi Kanbayashi, MD, PhD; Takayoshi Shimohata, MD, PhD; Ichiro Nakashima, MD, PhD; Hiroaki Yaguchi, MD; Ichiro Yabe, MD, PhD; Masatoyo Nishizawa, MD, PhD; Tetsuo Shimizu, MD, PhD; Seiji Nishino, MD, PhD
Topics: multiple sclerosis, narcolepsy, neuromyelitis optica
Arch Neurol. 2009;66(12):1563-1566.  doi: 10.1001/archneurol.2009.264
Subdural Fluid Collections in Patients With Infantile Neuronal Ceroid LipofuscinosisFluid Collection in Neuronal Ceroid Lipofuscinosis FREE
Sondra W. Levin, MD; Eva H. Baker, MD, PhD; Andrea Gropman, MD; Zenaide Quezado, MD; Ning Miao, MD; Zhongjian Zhang, MD, PhD; Alice Jollands, MD; Matteo Di Capua, MD; Rafael Caruso, MD; Anil B. Mukherjee, MD, PhD
Topics: neuronal ceroid-lipofuscinoses, subdural space
Arch Neurol. 2009;66(12):1567-1571.  doi: 10.1001/archneurol.2009.263
Shivering in Coma
Eelco F. M. Wijdicks, MD, PhD
Topics: coma, shivering
Arch Neurol. 2009;66(12):1572-1572.  doi: 10.1001/archneurol.2009.260
Lateral Medullary Syndrome and Ipsilateral Hemiplegia (Opalski Syndrome) Due to Left Vertebral Artery DissectionOpalski Syndrome From Vertebral Artery Dissection
Jorge García-García, MD; Óscar Ayo-Martín, MD; Tomás Segura, MD, PhD
Topics: lateral medullary syndrome, hemiplegia, vertebral artery dissection
Arch Neurol. 2009;66(12):1574-1575.  doi: 10.1001/archneurol.2009.268
Progressive Myopathy With Multiple Symmetric LipomatosisMyopathy With Multiple Symmetric Lipomatosis
Nicola Brunetti-Pierri, MD; Aziz Shaibani, MD; Shulin Zhang, PhD; Lee-Jun Wong, PhD; Marwan Shinawi, MD
Topics: lipomatosis, myopathy
Arch Neurol. 2009;66(12):1576-1577.  doi: 10.1001/archneurol.2009.239
Adams and Victor’s Principles of Neurology, 9th ed
Topics:
Arch Neurol. 2009;66(12):1578-1579.  doi: 10.1001/archneurol.2009.258
HIV and the Brain: New Challenges in the Modern Era
Topics:
Arch Neurol. 2009;66(12):1578-1579.  doi: 10.1001/archneurol.2009.257
Breastfeeding and Multiple Sclerosis
Raffaele Iorio, MD; Viviana Nociti, MD; Giovanni Frisullo, MD, PhD; Agata Katia Patanella, MD; Pietro A. Tonali, MD; Anna Paola Batocchi, MD, PhD
Topics: breast feeding, multiple sclerosis
Arch Neurol. 2009;66(12):1580-1581.  doi: 10.1001/archneurol.2009.280
Protective Effect of Breastfeeding in Postpartum Relapse Rate of Mothers With Multiple Sclerosis
Kerstin Hellwig, MD; Aiden Haghikia, MD; Heike Agne, MD; Christian Beste, PhD; Ralf Gold, MD
Topics: breast feeding, mothers, multiple sclerosis, postpartum period
Arch Neurol. 2009;66(12):1580-1581.  doi: 10.1001/archneurol.2009.281
Protective Effect of Breastfeeding in Postpartum Relapse Rate of Mothers With Multiple Sclerosis—Reply
Annette Langer-Gould, MD, PhD
Topics: breast feeding, mothers, multiple sclerosis, postpartum period
Arch Neurol. 2009;66(12):1580-1581.  doi: 10.1001/archneurol.2009.282

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems